
Centauri Therapeutics
Operator of a biotechnology company intended to discover and develop novel molecules and immunotherapy targeting life-threatening diseases. The company uses alphamer technology, in which chemically sy...
Valuation
$0
Share Price
N/A
Total Raised
$43M
Last Round
N/A